🇺🇸 FDA
Patent

US 12122853

Compositions and methods of inhibiting the binding of plasma IGG autoantibodies to serotonin 2A receptor

granted A61KA61K31/445A61K31/517

Quick answer

US patent 12122853 (Compositions and methods of inhibiting the binding of plasma IGG autoantibodies to serotonin 2A receptor) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/445, A61K31/517, A61K38/10, A61P